CXCL8 and neuroendocrine neoplasm: These results, in conjunction with imaging techniques, highlight the more versatile use of IL-8 in the clinical workflow when other pancreatic lesions, for instance, high-grade neuroendocrine tumours, metastases, etc., mimic PDAC [19,30,33].